Event Date: Dec 16, 2014
This webinar will examine how a robust, comprehensive and systematic Clinical Outcome Assessment (COA) endpoint strategy can meet the needs of all stakeholders in a single development program. We will review how biotech and pharmaceutical companies are benefitting from well thought out COA strategies from pre-Phase II through post-marketing research and the positive impact it is having on regulators, payers, healthcare professionals and patients / patient retention.
Event Details Available Here.
